Addus Homecare (ADUS) analyst forecast and price target
Analyst forecast
Consensus of 14 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Outperform | $134.00 from $130.00 | Aug 5, 2026 |
| Barclays | Maintained | Underweight | $96.00 from $92.00 | Jul 9, 2026 |
| Citizens | Maintained | Market Outperform | $142.00 | May 18, 2026 |
| Barclays | Maintained | Underweight | $92.00 from $102.00 | May 15, 2026 |
| Citizens | Maintained | Market Outperform | $142.00 from $150.00 | May 6, 2026 |
| Barclays | Maintained | Underweight | $102.00 from $112.00 | Mar 25, 2026 |
| Stephens & Co. | Maintained | Overweight | $135.00 from $140.00 | Feb 25, 2026 |
| Barclays | Maintained | Underweight | $112.00 from $117.00 | Feb 24, 2026 |
| BMO Capital | Initiated Coverage | Market Perform | $120.00 | Nov 13, 2025 |
| RBC Capital | Maintained | Outperform | $139.00 from $134.00 | Nov 7, 2025 |
| TD Cowen | Maintained | Buy | $140.00 from $139.00 | Nov 5, 2025 |
| Barclays | Maintained | Underweight | $117.00 from $111.00 | Nov 4, 2025 |
| Stephens & Co. | Maintained | Overweight | $140.00 | Sep 3, 2025 |
| UBS | Initiated Coverage | Buy | $145.00 | Sep 2, 2025 |
| RBC Capital | Maintained | Outperform | $134.00 from $133.00 | Aug 22, 2025 |
| Barclays | Maintained | Underweight | $109.00 from $83.00 | Aug 19, 2025 |
| TD Cowen | Maintained | Buy | $139.00 from $135.00 | Aug 6, 2025 |
| JMP Securities | Maintained | Market Outperform | $150.00 | Jul 16, 2025 |
| JMP Securities | Maintained | Market Outperform | $150.00 | Jun 20, 2025 |
| Macquarie | Maintained | Outperform | $133.00 | Jun 10, 2025 |
Frequently asked questions
Is ADUS a buy, sell, or hold?
Analysts covering Addus Homecare currently average a Buy rating: 12 buy, 1 hold and 1 sell, from 14 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on ADUS?
On Aug 5, 2026, RBC Capital maintained Addus Homecare at Outperform with a price target of $134.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.